<?xml version="1.0" encoding="UTF-8"?>
<p>The results of this pilot study suggest that a larger and more rigorous trial is feasible. Revisions to the inclusion criteria, immune reconstitution sampling rate, and monetary incentive to patients should make for a more manageable protocol.</p>
